Literature DB >> 11765062

Role of retinoblastoma tumor suppressor protein in DNA damage response.

J Y Wang1, S Naderi, T T Chen.   

Abstract

Growth arrest induced by DNA damage in mammalian cells requires the function of the retinoblastoma tumor suppressor protein (RB). RB-deficient cells cannot undergo G1, mid-S or G2 arrest following DNA damage, although they can activate the G2 checkpoint, which is reversible. RB-deficient cells are also hypersensitive to DNA damage-induced apoptosis. Induction of apoptosis in RB wild-type cells is associated with the loss of RB protein through cleavage by caspase. Two substitution mutations in exon 25 of the Rb gene have been created in the mouse germline to generate the Rb-MI allele that codes for a caspase-resistant RB protein. The RB-MI protein desensitizes cells to apoptosis. Taken together, these results suggest that RB plays a critical role in determining the cell fate following DNA damage. Growth arrest is dependent on RB and apoptosis is activated following RB degradation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11765062     DOI: 10.1080/02841860152619098

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  10 in total

Review 1.  Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage.

Authors:  Joanne M Bowen; Rachel J Gibson; Adrian G Cummins; Dorothy M K Keefe
Journal:  Support Care Cancer       Date:  2006-02-02       Impact factor: 3.603

2.  The Mechanisms of the Anti-Inflammatory and Anti-Apoptotic Effects of Omega-3 Polyunsaturated Fatty Acids during Methotrexate-Induced Intestinal Damage in Cell Line and in a Rat Model.

Authors:  Tal Koppelmann; Yulia Pollak; Yoav Ben-Shahar; Gregory Gorelik; Igor Sukhotnik
Journal:  Nutrients       Date:  2021-03-10       Impact factor: 5.717

3.  Microarray analysis of Shigella flexneri-infected epithelial cells identifies host factors important for apoptosis inhibition.

Authors:  Christina S Faherty; D Scott Merrell; Cristina Semino-Mora; Andre Dubois; Aishwarya V Ramaswamy; Anthony T Maurelli
Journal:  BMC Genomics       Date:  2010-04-29       Impact factor: 3.969

4.  Gene network landscape of the ciliate Tetrahymena thermophila.

Authors:  Jie Xiong; Dongxia Yuan; Jeffrey S Fillingham; Jyoti Garg; Xingyi Lu; Yue Chang; Yifan Liu; Chengjie Fu; Ronald E Pearlman; Wei Miao
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

5.  Reduced expression of the retinoblastoma protein shows that the related signaling pathway is essential for mediating the antineoplastic activity of erufosine.

Authors:  Maya M Zaharieva; Milen Kirilov; Minquang Chai; Stefan M Berger; Spiro Konstantinov; Martin R Berger
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

6.  Cytotoxic effects of tetracycline analogues (doxycycline, minocycline and COL-3) in acute myeloid leukemia HL-60 cells.

Authors:  Hairong Song; Mona Fares; Kim R Maguire; Ake Sidén; Zuzana Potácová
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

7.  Regulation of the Notch-ATM-abl axis by geranylgeranyl diphosphate synthase inhibition.

Authors:  Sherry S Agabiti; Jin Li; Willie Dong; Michael M Poe; Andrew J Wiemer
Journal:  Cell Death Dis       Date:  2019-09-30       Impact factor: 8.469

8.  The N-terminal domain of the Drosophila retinoblastoma protein Rbf1 interacts with ORC and associates with chromatin in an E2F independent manner.

Authors:  Joseph Ahlander; Xiao-Bo Chen; Giovanni Bosco
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

9.  Retinoblastoma protein expression is an independent predictor of both radiation response and survival in muscle-invasive bladder cancer.

Authors:  M Agerbaek; J Alsner; N Marcussen; F Lundbeck; H von der Maase
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

10.  CAPER as a therapeutic target for triple negative breast cancer.

Authors:  Mallory C Campbell; Laura Pontiggia; Ashley Y Russell; Roland Schwarting; Jeanette Camacho; Jean-Francois Jasmin; Isabelle Mercier
Journal:  Oncotarget       Date:  2018-07-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.